P3 Health Partners (PIII) Competitors $6.50 +0.15 (+2.36%) Closing price 04:00 PM EasternExtended Trading$6.62 +0.12 (+1.85%) As of 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PIII vs. DCGO, XGN, EUDA, SERA, QIPT, NAKA, KDLY, ATPC, CORBF, and OPGNShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), Global Cord Blood (CORBF), and OpGen (OPGN). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Its Competitors DocGo Exagen EUDA Health Sera Prognostics Quipt Home Medical KindlyMD Kindly MD Agape ATP Global Cord Blood OpGen DocGo (NASDAQ:DCGO) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability. Which has better valuation and earnings, DCGO or PIII? DocGo has higher earnings, but lower revenue than P3 Health Partners. DocGo is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$616.55M0.23$19.99M-$0.02-71.00P3 Health Partners$1.50B0.03-$135.85M-$47.28-0.14 Which has more volatility and risk, DCGO or PIII? DocGo has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Do analysts prefer DCGO or PIII? DocGo currently has a consensus target price of $3.56, indicating a potential upside of 150.70%. P3 Health Partners has a consensus target price of $16.25, indicating a potential upside of 150.00%. Given DocGo's higher possible upside, research analysts plainly believe DocGo is more favorable than P3 Health Partners.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50P3 Health Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is DCGO or PIII more profitable? DocGo has a net margin of -0.12% compared to P3 Health Partners' net margin of -9.27%. DocGo's return on equity of 2.52% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets DocGo-0.12% 2.52% 1.70% P3 Health Partners -9.27%-123.10%-15.94% Do insiders and institutionals believe in DCGO or PIII? 56.4% of DocGo shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 2.7% of DocGo shares are held by company insiders. Comparatively, 17.8% of P3 Health Partners shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer DCGO or PIII? In the previous week, DocGo and DocGo both had 1 articles in the media. DocGo's average media sentiment score of 1.89 equaled P3 Health Partners'average media sentiment score. Company Overall Sentiment DocGo Very Positive P3 Health Partners Very Positive SummaryDocGo beats P3 Health Partners on 10 of the 13 factors compared between the two stocks. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIII vs. The Competition Export to ExcelMetricP3 Health PartnersMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$45.64M$1.96B$5.52B$9.32BDividend YieldN/AN/A4.25%4.05%P/E Ratio-0.1434.3428.1519.68Price / Sales0.0315.28438.33100.29Price / CashN/A53.6035.5357.53Price / Book0.618.638.235.67Net Income-$135.85M-$62.39M$3.23B$257.51M7 Day Performance1.56%-1.66%-0.01%0.52%1 Month PerformanceN/A10.22%5.61%8.84%1 Year Performance-77.51%3.79%26.52%14.18% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIP3 Health Partners3.2381 of 5 stars$6.50+2.4%$16.25+150.0%-77.1%$45.64M$1.50B-0.14500Positive NewsDCGODocGo2.5595 of 5 stars$1.52-3.8%$3.56+134.2%-55.3%$161.13M$520.50M-76.004,407XGNExagen3.3336 of 5 stars$6.96-1.3%$7.50+7.8%+242.4%$150.16M$55.64M-8.29220News CoverageEUDAEUDA Health1.2536 of 5 stars$3.33-1.5%N/A-15.4%$125.59M$4.01M0.002SERASera Prognostics0.3995 of 5 stars$2.42-2.8%N/A-61.6%$93.81M$80K-2.57120QIPTQuipt Home Medical2.9519 of 5 stars$1.73-2.8%$2.85+64.7%-35.3%$77.33M$245.91M-8.241,200NAKAKindlyMDN/A$12.04-5.6%N/AN/A$76.88M$2.72M-15.64N/AKDLYKindly MDN/A$12.75-2.8%N/A+414.5%$76.78M$2.47M-16.56N/AATPCAgape ATP0.5442 of 5 stars$1.40+2.6%N/A-65.6%$68.01M$1.29M-2.3240Gap DownCORBFGlobal Cord BloodN/A$0.55-62.1%N/AN/A$66.85M$196.12M0.001,200Gap DownOPGNOpGenN/A$5.02+6.1%N/A+32.4%$50.54M$2.67M0.00100Gap Down Related Companies and Tools Related Companies DCGO Competitors XGN Competitors EUDA Competitors SERA Competitors QIPT Competitors NAKA Competitors KDLY Competitors ATPC Competitors CORBF Competitors OPGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PIII) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PIII Stock Alerts